logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
31/03/2026
The continuous main lithium carbonate contract rose by 5% intraday, now trading at 172500.00 yuan.
Latest
7 m ago
Weico Foods Company: We will continue to progress as planned and achieve our 2026 performance outlook.
7 m ago
According to the AI Fast News, Guotai Junan Securities released a research report on March 31, giving a "buy" rating to Zhongji Xuchuang (300308.SZ). The reasons for the rating include: 1) High income growth proves the high prosperity of the industry, actively stocking up and expanding production to safeguard future delivery; 2) Product high-speed upgrade + silicon light penetration rate improvement, continuously optimizing the company's profitability; 3) Prospective layout of the next generation of optical interconnection, opening up medium and long-term growth space. (Daily Economic News)
7 m ago
Each Economic AI Express, Open Source Securities published a research report on March 31, giving consistent konjac (920273.SH) a "buy" rating. The rating reasons mainly include: 1) 2025 annual report: revenue of 739 million yuan, a year-on-year increase of 20%; net profit attributable to mother of 66.72 million yuan, a year-on-year decrease of 23%; 2) the unit price of konjac powder has increased, and the rapid growth trend of tea drink ingredients, raw material price increase has put pressure on gross profit margin; 3) the company's research and development expenses increased by 16% year-on-year in 2025, with 28 invention patents. (Daily Economic News)
7 m ago
Jiahua Group: The controlling shareholder is planning a major event that may lead to a change in the company's controlling rights. Trading of the stock is suspended.
7 m ago
According to the AI quick news, Shanxi Securities issued a research report on March 31, affirming a "buy" rating for iMeike (300896.SZ). The reasons for the rating mainly include: 1) affected by macroeconomic environment and industry competition, the company's revenue for solution and gel products showed varying degrees of decline; 2) independent research and development + extension-based acquisitions enhance the company's industry layout and integration capabilities; 3) acquisitions and subsequent integration of international medical beauty targets accelerate the company's deep integration into the global medical beauty industry chain division of labor and cooperation. (Daily Economic News)
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.